Rank
Global leading causes of death, mapped to monitorable contexts
Ranked by estimated number of deaths for leading underlying causes. Counts are WHO estimates, not case-fatality rates and not personal risk rankings.
Ischaemic heart disease
#1 global cause, WHO GHE 2021
Cardiac blood supply, atherosclerotic vascular context, pressure load, lipids, glucose, kidney function, and metabolic reserve.
Blood pressure Blood pressure is directly measurable and often silent when high; repeated, correctly taken readings matter more than a single casual number.[6]
LDL cholesterol A lipid panel anchors cholesterol context; LDL and non-HDL are interpreted with vascular and metabolic risk context.[7,5]
Boundary: This global population rank does not mean every visitor's main risk is ischaemic heart disease; personal context belongs with a clinician.
COVID-19
#2 global cause, WHO GHE 2021
Pandemic-period respiratory infection burden, with oxygenation, respiratory rate, inflammation, age, immune, cardiovascular, metabolic, lung, and kidney context.
Oxygen saturation Oxygen saturation and respiratory rate can become acute-context signals, but they do not diagnose COVID-19 or replace clinical assessment.[8,9]
CRP Inflammation markers can enter severe-infection context, but they are nonspecific and must be interpreted with the whole clinical picture.[8]
Boundary: This 2021 global rank reflects the acute pandemic period. GBD 2023 reports that COVID-19 had dropped much lower in the global cause ranking by 2023.
Stroke / cerebrovascular disease
#3 global cause, WHO GHE 2021
Cerebrovascular events connect vascular load, rhythm context, lipids, glucose, kidney function, and brain reserve.
Blood pressure Blood pressure is a major vascular context variable and needs accurate measurement technique, not just a one-off reading.[6]
Heart rate and rhythm Rhythm context matters because atrial fibrillation can change stroke-prevention discussions; interpretation is clinician-guided.[10,11]
Boundary: Stroke symptoms are emergency context; this page is for parameter mapping, not acute triage.
Chronic obstructive pulmonary disease
#4 global cause, WHO GHE 2021
Airflow limitation, gas exchange, oxygenation, lung-function testing, imaging, exacerbation context, and lung reserve.
Airflow obstruction Spirometry and lung-function testing are central for airflow context; symptoms alone can mislead.[12,13,14]
Oxygen saturation Pulse oximetry is an oxygenation snapshot; it does not replace lung-function, imaging, or clinical assessment.[9,13]
Boundary: A normal-looking oxygen saturation does not rule out important lung disease or airflow obstruction.
Lower respiratory infections
#5 global cause, WHO GHE 2021
Pneumonia and lower-airway infection context, connecting oxygenation, respiratory rate, inflammatory response, imaging, age, and immune reserve.
Oxygen saturation Oxygenation and breathing rate can be acute severity-context signals, but infection diagnosis needs clinical and testing context.[15,9]
Chest imaging in lung context Chest imaging can help frame pneumonia or other lung-structure questions, but it is not interpreted in isolation.[15,13]
Boundary: Infection rows are kept because a global human-parameter map should not hide high-burden acute physiology.
Trachea, bronchus, and lung cancers
#6 global cause, WHO GHE 2021
Cancer burden concentrated in lung and airway malignancy context, where imaging, tissue diagnosis, molecular markers, and smoking or exposure history matter.
Chest imaging in lung context Lung-cancer context is not solved by a general blood marker; imaging, tissue diagnosis, and oncology review carry the meaning.[16,17]
Tumor marker context Tumor markers are not universal cancer screens; interpretation depends on cancer type, test purpose, and clinical context.[17]
Boundary: Do not reduce lung cancer to one blood marker; BioConst treats cancer parameters as pathway-specific context.
Alzheimer disease and other dementias
#7 global cause, WHO GHE 2021
Memory-network failure, cognitive testing, functional decline, amyloid/tau context, vascular context, and neurodegeneration boundaries.
Cognitive testing Cognitive tests observe function, not a single molecular cause; longitudinal context matters.[18,19]
Alzheimer biomarkers Alzheimer biomarkers can refine disease context, but they do not by themselves answer care, safety, or daily-function questions.[19]
Boundary: Dementia burden is not reducible to a single blood marker or one imaging finding.
Diabetes mellitus
#8 global cause, WHO GHE 2021
Glucose regulation, vascular injury, kidney risk, neuropathy context, body composition, and cardiovascular-kidney-metabolic overlap.
Hemoglobin A1c A1C estimates average glucose over about three months, but it is not the whole glucose story.[20,22]
Urine albumin-to-creatinine ratio (UACR) Kidney context matters because diabetes can affect microvascular filtration and albumin leakage.[21,23]
Boundary: Glucose parameters are interpreted with medications, anemia context, pregnancy context, kidney status, and clinician guidance.
Kidney diseases
#9 global cause, WHO GHE 2021
Filtration loss, albumin leakage, creatinine/cystatin C context, blood pressure, diabetes, fluid-electrolyte balance, and replacement-therapy thresholds.
eGFR / kidney function eGFR is a filtration estimate; trends and repeat confirmation matter more than one isolated number.[23]
Urine albumin-to-creatinine ratio (UACR) Urine albumin or UACR adds glomerular barrier context that filtration estimates alone can miss.[23]
Boundary: Kidney parameters are trend and context variables, not standalone labels of personal prognosis.
Tuberculosis
#10 global cause, WHO GHE 2021
A high-burden infectious disease, often pulmonary, connecting chronic cough context, microbiologic testing, chest imaging, inflammation, nutrition, immune status, and public-health detection.
Chest imaging in lung context TB diagnosis is not a generic blood-marker problem; WHO describes rapid molecular tests, sputum microscopy, and chest X-rays as diagnostic tools in the right context.[24]
Lung infection context Pulmonary infection context connects symptoms, exposure, microbiology, imaging, and public-health follow-up rather than one isolated parameter.[24]
Boundary: TB is communicable-disease and public-health context; BioConst maps parameters, not contact tracing or treatment decisions.
How to monitor / judge
How to monitor / judge
This ranks population-level underlying causes by estimated death count. It is not personal triage, diagnosis, or a test-ordering guide.
Blood pressure
Observed by: Measured in clinical settings, pharmacies, or with validated home monitors; repeated readings and correct technique matter.
Judgment traps: High blood pressure is often silent. Readings can be distorted by cuff fit, recent caffeine/exercise, posture, conversation, and white-coat context.
LDL / non-HDL cholesterol
Observed by: A lipid panel links LDL, HDL, triglycerides, and non-HDL cholesterol into vascular-risk context.
Judgment traps: Lipid numbers are interpreted with age, vascular history, diabetes, blood pressure, kidney function, and medication context.
A1C / glucose
Observed by: A1C estimates average glucose over about three months; glucose checks show shorter-term variation.
Judgment traps: A1C is useful but not the whole picture; it does not replace day-to-day glucose monitoring when clinically needed.
eGFR / urine albumin
Observed by: Kidney monitoring commonly combines GFR/eGFR with urine albumin or UACR.
Judgment traps: Trend matters. NIDDK describes GFR below 60 as possible kidney disease context and UACR above 30 mg/g as possible kidney-disease context that may need repeat confirmation.
Oxygenation and airflow
Observed by: Pulse oximetry gives an oxygenation snapshot; spirometry and lung-function tests supply airflow and reserve context.
Judgment traps: Normal oxygen saturation can coexist with meaningful lung disease; airflow, diffusion, symptoms, imaging, and clinical context answer different questions.
Cancer screening context
Observed by: Cancer monitoring uses pathway-specific tests such as FIT/FOBT, HPV/Pap context, PSA context, imaging, pathology, and tumor markers for selected uses.
Judgment traps: A tumor marker is not a universal cancer detector. Screening tests can have false positives and false negatives and depend on age, sex, organ system, and history.
Science watch
Science watch
Research themes where parameter control, selection, or monitoring is becoming strategically important.
Cardiovascular-kidney-metabolic systems
Theme: Control the shared risk loop across blood pressure, cholesterol, weight, blood sugar, and kidney function.
Why it matters: AHA frames cardiovascular, kidney, and metabolic health as an interconnected syndrome space rather than separate silos.
Boundary: CKM is a systems lens, not a self-treatment protocol.
GLP-1 class and metabolic-cardiovascular risk
Theme: Move from weight-only framing toward cardiovascular outcome and metabolic-risk framing in selected populations.
Why it matters: FDA approved semaglutide/Wegovy for reducing risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and obesity or overweight.
Boundary: Prescription-drug context, boxed warnings, contraindications, and adverse-effect monitoring are not public self-use advice.
Anti-amyloid treatment monitoring
Theme: Alzheimer disease frontier work is increasingly tied to biomarker selection, early disease context, and ARIA safety monitoring.
Why it matters: FDA-approved anti-amyloid therapies create a visible boundary between disease biology, treatment eligibility, and imaging safety surveillance.
Boundary: This is specialist treatment and monitoring context, not a memory-restoration promise.
Cellular senescence atlases
Theme: Identify senescent-cell types, locations, secreted molecules, and lifespan/body-state differences before claiming broad anti-aging control.
Why it matters: NIH SenNet is building public atlases and tools to characterize senescent cells across tissues, health states, and lifespan.
Boundary: Senescence is not yet a simple consumer biomarker; current BioConst links are bridge variables, not direct senescent-cell readouts.